NEIRG
GILD icon

New England Investment & Retirement Group’s Gilead Sciences GILD Stock Holding History

New England Investment & Retirement Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$328K Buy
4,689
+573
+14% +$40.3K 0.08% 79
2021
Q2 		$283K Buy
+4,116
New +$275K 0.06% 86
2020
Q3 		– Sell
-60,764
Closed -$4.67M – 71
2020
Q2 		$4.67M Buy
60,764
+3,628
+6% +$278K 1.18% 27
2020
Q1 		$4.27M Buy
+57,136
New +$3.95M 1.82% 17

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

New England Investment & Retirement Group's GILD Position: Q3 2021 in Review

New England Investment & Retirement Group increased its Gilead Sciences (GILD) stake by 14% in Q3 2021, buying an estimated $40.3K and bringing the position to 4,689 shares worth $328K. The position accounts for 0.08% of the portfolio, ranked #79.

New England Investment & Retirement Group first reported a position in GILD in Q1 2020 and has held it in 4 quarters since. The position peaked at $4.67M in Q2 2020. 1,564 funds tracked by Wall St. Rank hold GILD as of Q3 2021.

  • New England Investment & Retirement Group held 4,689 shares of Gilead Sciences worth $328K as of Q3 2021.
  • New England Investment & Retirement Group bought 573 Gilead Sciences shares in Q3 2021, an estimated $40.3K.
  • Gilead Sciences made up 0.08% of New England Investment & Retirement Group's portfolio in Q3 2021, its #79 holding.
  • New England Investment & Retirement Group first reported a position in Gilead Sciences in Q1 2020 and has held it in 4 quarters since.
  • New England Investment & Retirement Group's Gilead Sciences position peaked at $4.67M in Q2 2020.
  • 1,564 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2021.

Based on New England Investment & Retirement Group's 13F filing for Q3 2021, filed 28 Oct 2021.